1 / 34

Pharmaceutical Workforce situation analysis Country cases studies Mrs Helen Tata (WHO/EMP)

Pharmaceutical Workforce situation analysis Country cases studies Mrs Helen Tata (WHO/EMP) Dr Hiba Yassin (MOH Sudan). Overview. Context The Tool Case study findings Ghana Tanzania Nigeria Sudan Framework development Sudan Next Steps. Context.

gautam
Télécharger la présentation

Pharmaceutical Workforce situation analysis Country cases studies Mrs Helen Tata (WHO/EMP)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pharmaceutical Workforce situation analysisCountry cases studiesMrsHelen Tata (WHO/EMP) Dr Hiba Yassin (MOH Sudan)

  2. Overview • Context • The Tool • Case study findings • Ghana • Tanzania • Nigeria • Sudan • Framework development Sudan • Next Steps

  3. Context Under the EC/ACP/WHO joint programme of action on Pharmaceutical Policies and Programmes, there is strengthening HR capacity for the pharmaceutical sector in order to improve access to medicines Development of a framework for HR planning for the pharmaceutical sector is the expected output for the EC activity Against this background, some countries in Africa took up this activity in 2008 to strengthen the pharmaceutical human resources capacity in their countries. As a first step, an assessment to determine the capacity mix in the pharmaceutical sectors of their countries was carried out MPC in collaboration with HRH/HIG and FIP developed tools that have been used for these assessments.

  4. The tool • Five Questionnaires were developed for: • Ministry of Health professionals and regulatory bodies • Pharmacy education providers • Health facilities • Pharmaceutical manufacturers, wholesalers and medical stores • Job satisfaction for pharmacists • The WHO level II methodology was adapted for the study.

  5. Countries Involved • In 2009, the following countries used the tools with the support of MPC to assess the PHR situations: • Ghana • Nigeria • Sudan • Tanzania • July 2009, there was a regional meeting in Abuja, Nigeria to share experiences with the use of the tools and make recommendations on improvement. • The EDM/AFRO and HRH department provided facilitation at this meeting.

  6. Fine tuning the tools • Recommendations from the Abuja meeting informed the following: • Defining a set of indicators for each of the 5 questionnaires Indicators • Defining all the terms used in each questionnaire, and • Subsequently a glossary of words Glossary • Information sheet in which confidentiality of information collected is guaranteed.

  7. Pharmaceutical workforce ^2007 *2008 °2009

  8. Pharmacist workforce 2006 – 2009*Sudan – 2009 data not available

  9. Pharmacists by employment sector (%)

  10. Regional distribution pharmacist: Ghana Regional pharmacist densities per 10,000 population:

  11. Zonal pharmacist densities per 10,000 population: Nigeria

  12. Regional pharmacist densities per 10,000 population: Tanzania

  13. Regional pharmacist densities per 10,000 population: Sudan

  14. Annual pharmacist salary ranges in USD

  15. Pharmacist degree applicants and enrolments

  16. Pharmacy technician diploma applicants and enrolments

  17. Pharmacist vacancy rates in sampled facilities (%)

  18. % Pharmacists disagree on job satisfaction statements

  19. % Pharmacists that disagreed with statements on harassment and personal safety

  20. Pharmaceutical Human resources framework • In 2010, WHO supported Tanzania, Ghana Nigeria and Sudan on consultations with relevant stakeholders to build consensus • on key pharmaceutical human resources issues and priorities • identify policy goals and processes to form the basis of a pharmaceuticalstrategic development framework

  21. Development of Pharmaceutical Human Resources Framework in SudanDr Hiba YassinMOH

  22. Sudan: HR Consultation 2010 Consultative meeting August 2010 in Khartoum 27 key stakeholders (HRH, regulatory, insurance, poison's board etc.) participated with support of WHO and EC. Results from 2009 assessment informed discussions around: Key issues affecting HR planning, management and development Key policy objectives to address each issue identified Policy actions needed in short term and long term to achieve policy objectives Structures needed to achieve policy objectives Key stakeholders and their roles 22

  23. Consultation structure 23

  24. The Strategic Framework The framework will serve as a reference document for development of a costed pharmaceutical human resources plan. Pharmaceutical Human Resources plan to feed into the 2011 – 2020 plan for the National Ministry of Health. Strategic Framework for Pharmaceutical Human Resources Development 2011 – 2020 24

  25. Next Step: 25

  26. Group consultations in Sudan

  27. Group consultation in Nigeria

  28. Consensus on draft strategic framework developed by consultation participants: Ghana

  29. Consensus on draft strategic framework developed by consultation participants: Tanzania

  30. 4 Pharmaceutical HR conceptual framework • First four pharmaceutical human resources framework in Africa: Ghana, Nigeria, Sudan, Tanzania Shortages Distribution Skill mix

  31. Countries reports • Publication of reports: • Tanzania on the web • http://apps.who.int/medicinedocs/en/m/abstract/Js17397e/ • Ghana • http://www.hrhresourcecenter.org/node/3270. • Nigeria and • Sudan, before end of year

  32. Next Steps • Development of pharmaceutical human resources strategic plan (ongoing in Ghana and Tanzania) • Collaboration with development Partners to mobilize funds to implement plan

  33. Acknowledgement • European Commission • Mario Dal Poz, WHO/HRH/HIG • Neeru Gupta (idem) • Tana Wuliji (Global Develoop) • Edith Adrews, WHO/Ghana and MOH counterparts • Rose Shija, WHO/Tanzania and MOH counterparts • Ogori Taylor, WHO/Nigeria and MOH counterparts • Nahid Salih, WHO/Sudan and MOH counterparts • MPC Team-EMP-AFRO-EMRO

  34. Thank You

More Related